Chemotherapy for refractory. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Bone Marrow Tumor Cells, Cultured Hepatic Artery

Organisms1

Diseases79

Anemia, Refractory Breast Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Recurrence Neoplasms Anemia, Refractory, with Excess of Blasts Lymphoma, Non-Hodgkin Hodgkin Disease Neutropenia Nausea Vomiting Ovarian Neoplasms Testicular Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Adenocarcinoma Neoplasms, Germ Cell and Embryonal Colorectal Neoplasms Leukopenia Thrombocytopenia Leukemia, Myeloid, Acute Brain Neoplasms Bone Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Progression Germinoma Lymphoma Multiple Myeloma Osteosarcoma Peritoneal Neoplasms Liver Neoplasms Stomach Neoplasms Carcinoma Lymphatic Metastasis Carcinoma, Squamous Cell Lymphoma, Large B-Cell, Diffuse Sarcoma Leukemia, Myeloid Hematologic Diseases Leukemia Stomatitis Neoplasm, Residual Head and Neck Neoplasms Retroperitoneal Neoplasms Myelodysplastic Syndromes Mediastinal Neoplasms Lymphoma, B-Cell Central Nervous System Neoplasms Seminoma Pancreatic Neoplasms Acute Disease Neoplasms, Second Primary Colonic Neoplasms Fatigue Dysgerminoma Lymphoma, Follicular Neoplasms, Glandular and Epithelial Mesothelioma Mucositis Esophageal Neoplasms Soft Tissue Neoplasms Medulloblastoma Neuroblastoma Fever Rectal Neoplasms Urinary Bladder Neoplasms Epilepsy Bone Marrow Diseases Nasopharyngeal Neoplasms Drug-Related Side Effects and Adverse Reactions Pleural Neoplasms Anemia Glioma Leukemia, Lymphocytic, Chronic, B-Cell Ascites Prostatic Neoplasms Lymphoma, Mantle-Cell Retinal Neoplasms

Chemicals and Drugs78

Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Etoposide Methotrexate Carboplatin Paclitaxel Vinblastine Ifosfamide Cytarabine Taxoids Deoxycytidine Organoplatinum Compounds Antimetabolites, Antineoplastic Bleomycin Antineoplastic Agents, Alkylating Anthracyclines Antineoplastic Agents, Phytogenic Carmustine Antibodies, Monoclonal, Murine-Derived Camptothecin Melphalan Mitoxantrone Antibodies, Monoclonal Antibiotics, Antineoplastic Dacarbazine Antibodies, Monoclonal, Humanized Granulocyte Colony-Stimulating Factor Platinum Compounds Thiotepa Lomustine Mitomycin Tumor Markers, Biological Antiemetics Daunorubicin Tegafur Dexamethasone Thalidomide Bridged Compounds Vindesine Prednisolone Pyrazines Boronic Acids Platinum Topotecan Vidarabine Receptor, erbB-2 Oxonic Acid Idarubicin P-Glycoprotein Angiogenesis Inhibitors Mesna Asparaginase Anticonvulsants Receptors, Estrogen Recombinant Proteins Nimustine Antineoplastic Agents, Hormonal Tamoxifen Granisetron Quinazolines Arabinonucleosides Chlorambucil Immunosuppressive Agents Mitomycins Floxuridine 6-Mercaptopurine Radiopharmaceuticals Thioguanine Biomarkers, Pharmacological Nitrogen Mustard Compounds Immunologic Factors Fluorodeoxyglucose F18 Ondansetron Antigens, CD20 Drug Combinations Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Treatment Outcome Combined Modality Therapy Disease-Free Survival Drug Administration Schedule Neoadjuvant Therapy Survival Analysis Salvage Therapy Survival Rate Neoplasm Staging Prognosis Induction Chemotherapy Follow-Up Studies Transplantation, Autologous Infusions, Intravenous Chemotherapy, Cancer, Regional Perfusion Prospective Studies Hematopoietic Stem Cell Transplantation Clinical Trials as Topic Radiotherapy, Adjuvant Kaplan-Meier Estimate Radiotherapy Treatment Failure Drug Evaluation Infusions, Intra-Arterial Drug Therapy Palliative Care Radiotherapy Dosage Randomized Controlled Trials as Topic Maximum Tolerated Dose Bone Marrow Transplantation Feasibility Studies Fatal Outcome Administration, Oral Pilot Projects Multivariate Analysis Actuarial Analysis Hyperthermia, Induced Maintenance Chemotherapy Chemoradiotherapy Clinical Trials, Phase III as Topic Tomography, X-Ray Computed Cranial Irradiation Proportional Hazards Models Predictive Value of Tests Immunohistochemistry Remission Induction Clinical Trials, Phase II as Topic Risk Factors Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Immunotherapy Peripheral Blood Stem Cell Transplantation Infusions, Parenteral Mastectomy Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Cohort Studies Consolidation Chemotherapy Retreatment Positron-Emission Tomography Transplantation, Homologous Preoperative Care Antineoplastic Protocols Transplantation Conditioning Karnofsky Performance Status Radioimmunotherapy Leukocyte Count Magnetic Resonance Imaging Risk Assessment Tumor Burden Platelet Count Patient Selection

Psychiatry and Psychology1

Refractory Period, Psychological

Phenomena and Processes13

Refractory Period, Electrophysiological Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Drug Resistance Maximum Tolerated Dose Apoptosis Drug Resistance, Multiple Drug Synergism Gene Expression Regulation, Neoplastic Cell Survival Leukocyte Count Platelet Count

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Health Care28

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Clinical Trials as Topic Kaplan-Meier Estimate Treatment Failure Palliative Care Randomized Controlled Trials as Topic Feasibility Studies Fatal Outcome Pilot Projects Multivariate Analysis Actuarial Analysis Clinical Trials, Phase III as Topic Proportional Hazards Models Predictive Value of Tests Clinical Trials, Phase II as Topic Risk Factors Cohort Studies Age Factors Preoperative Care Antineoplastic Protocols Karnofsky Performance Status Risk Assessment Patient Selection

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Antineoplastic Agents Treatment Outcome Combined Modality Therapy Cisplatin Cyclophosphamide Doxorubicin Disease-Free Survival Etoposide Anemia, Refractory Drug Administration Schedule Refractory Period, Electrophysiological Neoadjuvant Therapy Survival Analysis Salvage Therapy Breast Neoplasms Survival Rate Neoplasm Staging Prognosis Drug Resistance, Neoplasm Lung Neoplasms Methotrexate Neoplasm Recurrence, Local Carboplatin Paclitaxel Vinblastine Ifosfamide Cytarabine Recurrence Neoplasms Taxoids Induction Chemotherapy Follow-Up Studies Anemia, Refractory, with Excess of Blasts Deoxycytidine Organoplatinum Compounds Antimetabolites, Antineoplastic Transplantation, Autologous Lymphoma, Non-Hodgkin Bleomycin Hodgkin Disease Antineoplastic Agents, Alkylating Time Factors Infusions, Intravenous Neutropenia Anthracyclines Nausea Antineoplastic Agents, Phytogenic Vomiting Ovarian Neoplasms Dose-Response Relationship, Drug Testicular Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Chemotherapy, Cancer, Regional Perfusion Prospective Studies Carmustine Antibodies, Monoclonal, Murine-Derived Hematopoietic Stem Cell Transplantation Camptothecin Adenocarcinoma Melphalan Mitoxantrone Antibodies, Monoclonal Clinical Trials as Topic Antibiotics, Antineoplastic Neoplasms, Germ Cell and Embryonal Colorectal Neoplasms Radiotherapy, Adjuvant Dacarbazine Kaplan-Meier Estimate Antibodies, Monoclonal, Humanized Granulocyte Colony-Stimulating Factor Radiotherapy Leukopenia Thrombocytopenia Leukemia, Myeloid, Acute Platinum Compounds Thiotepa Lomustine Brain Neoplasms Treatment Failure Bone Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Progression Cell Line, Tumor Germinoma Drug Evaluation Infusions, Intra-Arterial Lymphoma Multiple Myeloma Mitomycin Tumor Markers, Biological Osteosarcoma Peritoneal Neoplasms Liver Neoplasms Antiemetics Drug Therapy Palliative Care

No FAQ available that match "chemotherapy for refractory"